Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guofen Yan

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Clinical Journal of the American Society of Nephrology : CJASN|December 21, 2019
Racial and Ethnic Variations in Mortality Rates for Patients Undergoing Maintenance Dialysis Treated in US Territories Compared with the US 50 StatesGuofen Yan, Jenny I Shen, Rubette Harford, et al.
Kidney International|June 18, 2004
Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO StudyMark Unruh, Robert Benz, Tom Greene, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 28, 2006
Hemodialysis timing, survival, and cardiovascular outcomes in the Hemodialysis (HEMO) StudyYue-Harn Ng, Klemens B Meyer, John W Kusek, et al.
Journal of the American Society of Nephrology : JASN|December 31, 2005
Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO studyAlfred K Cheung, Michael V Rocco, Guofen Yan, et al.
Epilepsia|March 31, 2018
Radiosurgery versus open surgery for mesial temporal lobe epilepsy: The randomized, controlled ROSE trialNicholas M Barbaro, Mark Quigg, Mariann M Ward, et al.
Epilepsia|June 12, 2019
Direct and indirect costs associated with stereotactic radiosurgery or open surgery for medial temporal lobe epilepsy: Results from the ROSE trialJohn T Langfitt, Mark Quigg, Guofen Yan, et al.
Seizure|November 9, 2018
Visual field defects after radiosurgery versus temporal lobectomy for mesial temporal lobe epilepsy: Findings of the ROSE trialMark Quigg, Nicholas M Barbaro, Mariann M Ward, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Clinical Journal of the American Society of Nephrology : CJASN|December 21, 2019
Racial and Ethnic Variations in Mortality Rates for Patients Undergoing Maintenance Dialysis Treated in US Territories Compared with the US 50 StatesGuofen Yan, Jenny I Shen, Rubette Harford, et al.
Kidney International|June 18, 2004
Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO StudyMark Unruh, Robert Benz, Tom Greene, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 28, 2006
Hemodialysis timing, survival, and cardiovascular outcomes in the Hemodialysis (HEMO) StudyYue-Harn Ng, Klemens B Meyer, John W Kusek, et al.
Journal of the American Society of Nephrology : JASN|December 31, 2005
Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO studyAlfred K Cheung, Michael V Rocco, Guofen Yan, et al.
Epilepsia|March 31, 2018
Radiosurgery versus open surgery for mesial temporal lobe epilepsy: The randomized, controlled ROSE trialNicholas M Barbaro, Mark Quigg, Mariann M Ward, et al.
Epilepsia|June 12, 2019
Direct and indirect costs associated with stereotactic radiosurgery or open surgery for medial temporal lobe epilepsy: Results from the ROSE trialJohn T Langfitt, Mark Quigg, Guofen Yan, et al.
Seizure|November 9, 2018
Visual field defects after radiosurgery versus temporal lobectomy for mesial temporal lobe epilepsy: Findings of the ROSE trialMark Quigg, Nicholas M Barbaro, Mariann M Ward, et al.
Pageof 8